Robert J. Shovlin, President, Clinical Services at NEOGENOMICS INC (NEO), sold 238,694 shares at $22.14 ($5.3M) on 2019-05-02, disclosed to the SEC on 2019-05-06.
Open-market sale of $5.3M NEO by President, Clinical Services. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.14 | 52,680 | $1.2M | 22.1% |
| 2 | $22.14 | 52,680 | $1.2M | 22.1% |
| 3 | $22.14 | 66,667 | $1.5M | 27.9% |
| 4 | $22.14 | 66,667 | $1.5M | 27.9% |
| Total | $22.14 avg | 238,694 | $5.3M | 100% |
| Filing → |
| NEO | SELL | 2020-03-05 | $6.1M | — | Filing → |
| NEO | SELL | 2019-11-04 | $4.9M | — | Filing → |
| NEO | SELL | 2019-02-28 | $7.1M | — | Filing → |